# Minaris Regenerative Medicine, LLC – FDA Inspection, Sep 29, 2025

Source: https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/9080b763-c431-455a-aed1-0c069db6f2aa
Source feed: FDA_Inspections

> FDA inspection 1284408 of Minaris Regenerative Medicine, LLC, September 29, 2025. 3 citations under 21 CFR parts 211 and 314. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1284408
- Company Name: Minaris Regenerative Medicine, LLC
- Inspection Date: 2025-09-29
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: New Jersey District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1224145 - 2023-09-25](https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/67457ed3-fd4a-4ea8-9ff2-b34c5e919157)
- FDA Inspection 1101234 - 2019-08-26
- FDA Inspection 1020396 - 2017-04-26
- [FDA Inspection 886646 - 2014-06-17](https://www.keypedia.com/records/fda_inspections/minaris-regenerative-medicine-llc/5a81bec9-2040-4d3a-a7ed-8fcfe398509d)

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/lizaida-perez/686fbdca-bfd7-4a73-990a-d8a97e6b88b7)
- [FDA Associated Person](https://www.keypedia.com/people/shafiq-s-ahadi/dd146b0a-ca1c-4052-8f50-4d68e14ad73f)

Company: https://www.keypedia.com/companies/minaris-regenerative-medicine-llc/b5fdb186-e2e7-416c-b89e-66d15dbf5509

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
